Key facts for Q5103
- Billing unit
- 10 MG
- Injection, inflectra
- ASP payment limit
- $28.456
- October 2026; +2.7% vs July 2026
- Practitioner MUE
- 150
- MAI 3
- NCCI exposure
- no PTP pairs
- Coverage articles
- 2
- 9 states
TL;DR
HCPCS Q5103 is the Level II code for Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg, billed per 10 MG. The Medicare Part B ASP payment limit for October 2026 is $28.456 per billing unit, up 2.7% from July 2026. The practitioner MUE allows up to 150 units per date of service (MAI 3), so a full 150-unit day is $4,268.40 at the current limit. Under OPPS it carries status indicator K in APC 1847. As a biosimilar it has its own code and ASP; the reference product cannot be billed under this code, and the JZ or JW modifier rules for discarded amounts apply per single-dose vial. The 10 mg billing unit means doses are reported in multiples of ten milligrams, with any remainder rounded per contractor policy; mismatched units against the NDC quantity trigger MUE and NDC-unit edits. Other HCPCS codes whose descriptor names infliximab: Q5104 (biosimilar infliximab-abda (Renflexis) from Organon LLC); Q5121 (biosimilar infliximab-axxq (Avsola) from Amgen Inc); J1745 (non-biosimilar infliximab from Janssen Biotech, Inc). The ASP crosswalk maps 1 NDC to it, sold as Inflectra by Pfizer Inc. 2 Medicare coverage articles list the code across 9 states, including A52423.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for Q5103 at $28.456 per 10 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $27.71 in July 2026. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $28.456 | 10 MG | 20% |
| July 2026 | $27.71 | 10 MG | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to Q5103. Report the NDC in the claim's drug segment and bill the number of Q5103 units that equals the quantity administered divided by 10 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 00069-0809-01 | Inflectra | Pfizer Inc | 1 × 1 | 10 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for Q5103. For practitioners the limit is 150 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 150 | 3 Date of Service Edit: Clinical | Prescribing Information |
| Facility outpatient hospital | 150 | 3 Date of Service Edit: Clinical | Prescribing Information |
| DME supplier | 0 | 3 Date of Service Edit: Clinical | CMS Policy |
MUE for Q5103 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists Q5103 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check Q5103 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
Q5103 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
2 current Medicare Administrative Contractor articles list Q5103 in their HCPCS tables, covering 9 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.
Diagnoses Medicare contractors cover for Q5103
2 billing and coding articles attach a covered diagnosis list to Q5103: 692 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).
| ICD-10-CM | Description (FY2027) | Articles covering |
|---|---|---|
| K50.00 | Crohn's disease of small intestine without complications | 2 of 2 |
| K50.011 | Crohn's disease of small intestine with rectal bleeding | 2 of 2 |
| K50.012 | Crohn's disease of small intestine with intestinal obstruction | 2 of 2 |
| K50.013 | Crohn's disease of small intestine with fistula | 2 of 2 |
| K50.014 | Crohn's disease of small intestine with abscess | 2 of 2 |
| K50.018 | Crohn's disease of small intestine with other complication | 2 of 2 |
| K50.019 | Crohn's disease of small intestine with unspecified complications | 2 of 2 |
| K50.10 | Crohn's disease of large intestine without complications | 2 of 2 |
| K50.111 | Crohn's disease of large intestine with rectal bleeding | 2 of 2 |
| K50.112 | Crohn's disease of large intestine with intestinal obstruction | 2 of 2 |
| K50.113 | Crohn's disease of large intestine with fistula | 2 of 2 |
| K50.114 | Crohn's disease of large intestine with abscess | 2 of 2 |
| K50.118 | Crohn's disease of large intestine with other complication | 2 of 2 |
| K50.119 | Crohn's disease of large intestine with unspecified complications | 2 of 2 |
| K50.80 | Crohn's disease of both small and large intestine without complications | 2 of 2 |
Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to Q5103 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.
| Article | Contractor | Groups that apply | Covered codes for Q5103 | Full list |
|---|---|---|---|---|
| A52423 | Wellpoint Federal | one list for every code in the article | 619 | On LCD L33394 |
| A56432 | Palmetto GBA | one list for every code in the article | 406 | On LCD L35677 |
Local coverage policies that list Q5103
2 active Local Coverage Determinations list Q5103 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- Drugs and Biologicals, Coverage of, for Label and Off-Label Uses (L33394) · Wellpoint Federal
- LCD L35677: Infliximab · Palmetto GBA
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, Q5103 carries status indicator K and is assigned to APC 1847, with a published national unadjusted payment of $28.456. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), Q5103 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $28.46 per 10 MG, paid only when the drug is furnished integral to a covered surgical procedure.
Common denials for Q5103 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for Q5103
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS Q5103
What does HCPCS code Q5103 describe?
Q5103 is defined by CMS as "Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg". Each billing unit represents 10 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is Q5103 a CPT code?
No. Q5103 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as infliximab-dyyb (Inflectra); CPT codes are five-character codes maintained by the AMA. On a Part B claim Q5103 reports the drug itself in 10 mg units, and the administration is billed on its own line.
What is the Medicare reimbursement for Q5103 in October 2026?
The ASP-based payment limit is $28.456 per 10 MG, with 20% beneficiary coinsurance. The July 2026 limit was $27.71. Commercial payers use their own fee schedules.
How many units of Q5103 can be billed per day?
The practitioner Medically Unlikely Edit is 150 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.
Which NDCs map to Q5103?
The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Inflectra (Pfizer Inc). For example NDC 00069-0809-01 (package size 1) equals 10 billing units of Q5103.
Does Q5103 have NCCI bundling edits?
No active practitioner PTP pairs list Q5103 as a column-1 or column-2 code in the v323r0 release.
Q5103 vs Q5104: what is the difference?
Both are HCPCS Level II codes whose descriptor names infliximab. What sets Q5104 apart: biosimilar infliximab-abda (Renflexis) from Organon LLC. Q5103 is billed per 10 mg, limit $28.456, MUE 150; Q5104 is billed per 10 mg, limit $25.649, MUE 150. Report the code whose descriptor matches the product and setting in the record.
Q5103 vs Q5121: what is the difference?
Both are HCPCS Level II codes whose descriptor names infliximab. What sets Q5121 apart: biosimilar infliximab-axxq (Avsola) from Amgen Inc. Q5103 is billed per 10 mg, limit $28.456, MUE 150; Q5121 is billed per 10 mg, limit $34.686, MUE 150. Report the code whose descriptor matches the product and setting in the record.
Which Medicare coverage articles mention Q5103?
2 current Billing and Coding Articles in the Medicare Coverage Database list Q5103, covering 9 states: A52423 (Billing and Coding: Infliximab and biosimilars); A56432 (Billing and Coding: Infliximab).
What diagnosis codes support Q5103?
2 Medicare billing and coding articles list 692 covered ICD-10-CM codes for Q5103 between them, for example K50.00 (Crohn's disease of small intestine without complications); K50.011 (Crohn's disease of small intestine with rectal bleeding); K50.012 (Crohn's disease of small intestine with intestinal obstruction); K50.013 (Crohn's disease of small intestine with fistula); K50.014 (Crohn's disease of small intestine with abscess). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- ICD-10-CM FY2027 code descriptionsVersion FY2027 · effective 2026-10-01 · file icd10cm_codes_2027.txtSHA-256 3c0583a38ee0e848…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.